Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients
Cancers · 15.07.2024 · 16 (14) · 2547
DOI: 10.3390/cancers16142547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 15.07.2024. Verfasst von Ava Kwong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The University of Hong Kong, Hong Kong SAR, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Ellen Li Charitable Foundation, Kerry Kuok Foundation, Health and Medical Research Fund.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Double pathogenic mutations occurring in an individual are considered a rare event. The introduction of a multiple-gene panel at Hong Kong Hereditary Breast Cancer Family Registry has allowed the identification of pathogenic variants in multiple genes, providing more information on clinical management and surveillance to the proband and their family members. Breast cancer patients who are double heterozygous (DH) for different hereditary breast and ovarian cancer syndrome (HBCO)-related genes were identified from a cohort of 3649 Chinese patients. Nine patients (0.25%) were observed to have germline DH mutations in ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, MSH6, PALB2, and TP53. Three probands were diagnosed with unilateral breast cancer, two patients were diagnosed with bilateral breast cancer, and four patients had multiple primary cancers. The median age for breast cancer diagnosis was an early age of 36 years. Chinese DH carriers did not show worse phenotypes or have a significantly downhill clinical presentation. However, seven out of nine (77.8%) of our DH carriers harbored a BRCA1 mutation, and four of them (44.4%) developed bilateral breast cancer, suggesting Chinese DH individuals may have a higher chance of having bilateral breast cancer than other populations (p = 0.0237).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, The University of Hong Kong, Hong Kong SAR, China.
- Department of Surgery, Hong Kong Sanatorium & Hospital, Hong Kong SAR, China.
- Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong SAR, China.
- Department of Molecular Pathology, Hong Kong Sanatorium & Hospital, Hong Kong SAR, China.
ORCID-Profile: Ava Kwong, Chun-Hang Au, Edmond S K Ma
Förderung
- Dr. Ellen Li Charitable Foundation
- Kerry Kuok Foundation
- Health and Medical Research Fund
- Asian Fund for Cancer Research
- Hong Kong Hereditary Breast Cancer Family Registry
Zitieren
APA
Kwong, A., Ho, C. Y. S., Au, C. H., & Ma, E. S. K. (2024). Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers, 16(14), 2547. https://doi.org/10.3390/cancers16142547
Vancouver
Kwong A, Ho CYS, Au CH, Ma ESK. Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers. 2024;16(14):2547. doi:10.3390/cancers16142547
BibTeX
@article{Kwong2024,
author = {Kwong, Ava and Ho, Cecilia Y S and Au, Chun-Hang and Ma, Edmond S K},
title = {Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients},
journal = {Cancers},
year = {2024},
volume = {16},
number = {14},
pages = {2547},
doi = {10.3390/cancers16142547}
}
EUVIMED